Feed SCYX
SC

SCYNEXIS, Inc.

SCYX · NASDAQ

$4.40 -0.34% (-$0.01)
1M -15.21%
Market Cap $28.0M
P/E Ratio -
Div. Yield -
ROE 21.10%
Piotroski F-Score Weak
2/9
Valuation
96 /100
Cheap
P/S 1.46x
P/B 0.42x
P/E N/A
Growth
100 /100
Growing
Rev. growth 59.35%
Book val. growth 148.11%
EPS growth N/A
Profitability
20 /100
Weak
Gross margin 100.00%
Net margin 53.27%
Op. margin 117.61%
Quality
3 /100
Poor
ROIC 32.44%
ROE 21.10%
ROA 13.65%
Debt
100 /100
Low
Debt/Equity 0.03x
Current ratio 9.65x
Int. coverage N/A
Stability
19 /100
Unstable
Beta 1.11x
Rev. volatility 1,455.71%
EPS volatility 164.02%

Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe

Întreabă StockBot despre SCYX
Online

Despre companie

SCYNEXIS, Inc. (SCYX) is a biotechnology company specializing in research, development, and commercialization of novel drugs for the treatment of infectious diseases. The company focuses on the discovery and development of innovative drugs targeting various types of infectious diseases, including fungal infections and resistant bacteria. SCYNEXIS aims to develop drugs that are effective and safe for patients with infectious diseases and can bring improvements in the treatment of these conditions. The company also conducts clinical trials and collaborates with medical institutions and pharmaceutical companies to further develop and commercialize its drugs. SCYNEXIS, Inc. (SCYX) shares may be an attractive investment opportunity for investors interested in the biotechnology sector and seeking an investment in a company with a focus on developing new drugs for the treatment of infectious diseases.

Nu este încă disponibil în limba dumneavoastră, așa că textul este în engleză.

Sector

Healthcare

Industry

Medical - Pharmaceuticals

CEO

David Angulo

Employees

18

Headquarters

Jersey City

Evenimente viitoare

04 NOV.

Earnings

Upcoming earnings report

44d

Folosim cookie-uri esențiale pentru funcționarea site-ului și cookie-uri analitice opționale pentru a măsura utilizarea. Consultați Politica de confidențialitate.